Akili raises an additional $11.9M; brings Amgen, Merck, Pfizer and Shire to the digital medicine table

By SharpBrains | July 21, 2016

—– Akili Adds Amgen Ven­tures and M Ven­tures* to Series B Financ­ing, Increas­ing Round to $42.4 Mil­lion (press release): “Akili Inter­ac­tive Labs, Inc. (“Akili”), a dig­i­tal med­i­cine com­pa­ny devel­op­ing nov­el, non-phar­­ma­­co­log­i­­cal ther­a­peu­tics and diag­nos­tics for cog­ni­tive dis­or­ders, today announced an $11.9 mil­lion expan­sion of its recent Series B financing. 

Read More

Upcoming webinar: The State of the Dig­i­tal Brain Health Mar­ket (Jan­u­ary 30th, 2013)

By SharpBrains | December 27, 2012

We will dis­cuss the main find­ings and inno­va­tion opportunities/ chal­lenges iden­ti­fied in Sharp­Brains’ new mar­ket report The Dig­i­tal Brain Health Mar­ket 2012–2020: Web-based, mobile and bio­met­rics-based tech­nol­ogy to assess, mon­i­tor and enhance cog­ni­tion and brain func­tion­ing. When: Wednes­day, Jan­u­ary 30th, 2013, 1–2.30pm US East­ern Time (live webi­nar will be record­ed for lat­er view­ing by registrants)

Read More